Wegovy Wegovy is a glucagon-like peptide 1 (GLP-1) receptor agonist, which means it tricks the body into thinking levels of the GLP-1 hormone are high
Although semaglutide had clearly been reported in clinical trials for increasing the risk of acute pancreatitis and pancreatic cancer, as well as promoting levels of lipase and amylase, several meta-analyses had revealed contrary results (4, 38)
The formula behind these numbers is simple
What is the disadvantage of peptides
Are oral or sublingual GLP-1 formulations better for dry mouth
We are a full-service med spa that offers a wide range of cosmetic and wellness services, including semaglutide, BOTOX, IPL, and more